Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Amylidi AL"'
Autor:
Amylidi AL; Oncomedicare Oncology Group, Thessaloniki, Greece.; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece., Kontovinis L; Oncomedicare Oncology Group, Thessaloniki, Greece.; Medical Oncology Department, Euromedica General Clinic, Thessaloniki, Greece., Douganiotis G; Oncomedicare Oncology Group, Thessaloniki, Greece., Natsiopoulos I; Interbalkan European Medical Center, Thessaloniki, Greece., Papazisis K; Oncomedicare Oncology Group, Thessaloniki, Greece.; Medical Oncology Department, Euromedica General Clinic, Thessaloniki, Greece.; Interbalkan European Medical Center, Thessaloniki, Greece.
Publikováno v:
Cancer diagnosis & prognosis [Cancer Diagn Progn] 2024 Nov 03; Vol. 4 (6), pp. 775-782. Date of Electronic Publication: 2024 Nov 03 (Print Publication: 2024).
Autor:
Bouratzis V; Second Department of Cardiology, University of Ioannina Medical School, University Campus, Stavros Niarchos Avenue, Ioannina 45 500, Greece., Lakkas L; Physiology Department, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina 45 110, Greece., Floros C; Second Department of Cardiology, University of Ioannina Medical School, University Campus, Stavros Niarchos Avenue, Ioannina 45 500, Greece., Amylidi AL; Department of Medical Oncology, University Hospital of Ioannina, Ioannina 45500, Greece., Douskou N; Second Department of Cardiology, University of Ioannina Medical School, University Campus, Stavros Niarchos Avenue, Ioannina 45 500, Greece., Stamou I; Second Department of Cardiology, University of Ioannina Medical School, University Campus, Stavros Niarchos Avenue, Ioannina 45 500, Greece., Naka KK; Second Department of Cardiology, University of Ioannina Medical School, University Campus, Stavros Niarchos Avenue, Ioannina 45 500, Greece.
Publikováno v:
European heart journal. Imaging methods and practice [Eur Heart J Imaging Methods Pract] 2024 Oct 24; Vol. 2 (3), pp. qyae110. Date of Electronic Publication: 2024 Oct 24 (Print Publication: 2024).
Autor:
Yerolatsite M; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece., Torounidou N; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece., Amylidi AL; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece., Kapoulitsa F; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece., Kampletsas E; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece., Zarkavelis G; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece., Mauri D; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece.
Publikováno v:
Case reports in oncology [Case Rep Oncol] 2024 Mar 04; Vol. 17 (1), pp. 417-422. Date of Electronic Publication: 2024 Mar 04 (Print Publication: 2024).
Autor:
Zarkavelis G; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece., Amylidi AL; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece., Torounidou N; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece., Yerolatsite M; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece., Keravasili A; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece., Keramisanou V; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece., Mauri D; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece.
Publikováno v:
Contemporary oncology (Poznan, Poland) [Contemp Oncol (Pozn)] 2024; Vol. 28 (1), pp. 45-50. Date of Electronic Publication: 2024 Apr 17.
Autor:
Amylidi AL; Department of Medical Oncology, University Hospital of Ioannina, 45500 Ioannina, Greece.; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), 45445 Ioannina, Greece., Gogadis A; Department of Medical Oncology, University Hospital of Ioannina, 45500 Ioannina, Greece.; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), 45445 Ioannina, Greece., Yerolatsite M; Department of Medical Oncology, University Hospital of Ioannina, 45500 Ioannina, Greece.; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), 45445 Ioannina, Greece., Zarkavelis G; Department of Medical Oncology, University Hospital of Ioannina, 45500 Ioannina, Greece.; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), 45445 Ioannina, Greece., Torounidou N; Department of Medical Oncology, University Hospital of Ioannina, 45500 Ioannina, Greece.; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), 45445 Ioannina, Greece., Keramisanou V; Department of Medical Oncology, University Hospital of Ioannina, 45500 Ioannina, Greece.; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), 45445 Ioannina, Greece., Kampletsas E; Department of Medical Oncology, University Hospital of Ioannina, 45500 Ioannina, Greece.; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), 45445 Ioannina, Greece., Mauri D; Department of Medical Oncology, University Hospital of Ioannina, 45500 Ioannina, Greece.; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), 45445 Ioannina, Greece.; Faculty of Medicine, School of Health Sciences, University of Ioannina, 45500 Ioannina, Greece.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Dec 18; Vol. 30 (12), pp. 10509-10518. Date of Electronic Publication: 2023 Dec 18.
Autor:
Zarkavelis G; University of Ioannina-Department of Medical Oncology, Ioannina, Greece., Amylidi AL; University of Ioannina-Department of Medical Oncology, Ioannina, Greece., Verbaanderd C; European Medicines Agency, Amsterdam, the Netherlands., Cherny NI; Cancer Pain and Palliative Medicine Service, Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Metaxas Y; Kantonsspital Münsterlingen, Münsterlingen, Switzerland., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Zygoura P; Frontier Science Foundation-Hellas, Athens, Greece., Amaral T; Skin Cancer Center, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany., Jordan K; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany; Department of Hematology, Oncology and Palliative Medicine, Ernst von Bergmann Hospital Potsdam, Potsdam, Germany., Strijbos M; GZA Ziekenhuizen Campus Sint-Augustinus, Antwerp, Belgium., Dafni U; Frontier Science Foundation-Hellas, Athens, Greece; Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece., Latino N; ESMO Head Office, Lugano, Switzerland., Galotti M; ESMO Head Office, Lugano, Switzerland., Lordick F; Department of Oncology, Gastroenterology, Hepatology, Pulmonology and Infectious Diseases, University Cancer Center Leipzig (UCCL), Leipzig University Medical Center, Leipzig, Germany., Giuliani R; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK., Pignatti F; European Medicines Agency, Amsterdam, the Netherlands., Pentheroudakis G; ESMO Head Office, Lugano, Switzerland. Electronic address: george.pentheroudakis@esmo.org.
Publikováno v:
ESMO open [ESMO Open] 2023 Feb; Vol. 8 (1), pp. 100604. Date of Electronic Publication: 2022 Nov 14.
Autor:
Mauri D; Department of Medical Oncology, University of Ιoannina, Ιoannina, Greece., Kamposioras K; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom., Matthaios D; Department of Oncology, General Hospital of Rhodes, Rhodes, Greece., Tolia M; Department of Radiotherapy/Radiation Oncology, Faculty of Medicine, University of Crete, Heraklion, Greece, mariatolia1@gmail.com., Nixon I; Scottish Sarcoma Network (SSN) UK Chair NCRI HN Epidemiology and Survivorship Subgroup, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Dambrosio M; Department of Medical Oncology, Clinica San Carlo, Paderno Dugnano, Italy., Zarkavelis G; Department of Medical Oncology, University of Ιoannina, Ιoannina, Greece., Papadimitriou K; University Hospital of Antwerp, Antwerp, Belgium., Petricevic B; Department of Hematology and Oncology, Klinik Ottakring, Vienna, Austria., Kountourakis P; Medical Oncology Department, Bank of Cyprus Oncology Centre, Nicosia, Cyprus., Kopecky J; Department of Clinical Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czechia., Grašič Kuhar C; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Popovic L; Medical Oncology Department, Oncology Institute of Vojvodina, University of Novi Sad, Novi Sad, Serbia., Chilingirova NP; Medical Oncology Clinic at Specialized Hospital for Active Treatment in Oncology, University Pleven, Sofia, Bulgaria., De Mello RA; Department of Biomedical Sciences & Medicine, University of Algarve, Faro, Portugal.; Precision Oncology Group, Federal University of São Paulo (UNIFESP), & Nine of July University (UNINOVE), São Paulo, Brazil., Dedić Plavetić N; Department of Oncology, University Hospital Centre Zagreb, University of Zagreb, School of Medicine, Zagreb, Croatia., Katsanos K; Department of Gastroenterology, University Hospital of Ioannina, Ιoannina, Greece., Mostert B; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Alongi F; Advanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Center, Verona, Italy.; University of Brescia, Brescia, Italy., de Bari B; Hospitalier Neuchâtelois, La Chaux-de-Fonds, Switzerland., Corradini S; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Kampletsas E; Department of Medical Oncology, University of Ιoannina, Ιoannina, Greece., Gazouli I; Department of Medical Oncology, University of Ιoannina, Ιoannina, Greece., Gkoura S; Department of Medical Oncology, University of Ιoannina, Ιoannina, Greece., Amylidi AL; Department of Medical Oncology, University of Ιoannina, Ιoannina, Greece., Valachis A; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Publikováno v:
Oncology research and treatment [Oncol Res Treat] 2022; Vol. 45 (4), pp. 216-221. Date of Electronic Publication: 2022 Jan 09.
Autor:
Mauri D; Department of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece., Kampletsas E; Department of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece., Smyris G; Department of Architectural Engineering, Architecture Faculty, University of Ioannina, Ioannina, Greece., Tsali L; PACMeR, Department of Evidence Based Medicine, Athens, Greece., Tsekeris P; Department of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece., Harissis H; Department of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece., Kamposioras K; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom., Tolia M; Department of Radiotherapy, School of Medicine, University of Crete, Heraklion, Greece., Hyphantis T; Department of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece., Ntellas P; Department of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece., Gazouli I; Department of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece., Zarkavelis G; Department of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece., Mavroeidis L; Department of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece., Amylidi AL; Department of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece., Torounidou N; Department of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece., Gogadis A; Department of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece., Nixon J; Department of Radiotherapy, Scottish Sarcoma Network (SSN) UK Chair NCRIHN Epidemiology and Survivorship Subgroup, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
Publikováno v:
Palliative medicine reports [Palliat Med Rep] 2021 Dec 27; Vol. 2 (1), pp. 365-368. Date of Electronic Publication: 2021 Dec 27 (Print Publication: 2021).
Autor:
Kamposioras K; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Ntellas P; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece., Nikolaou M; Department of Medical Oncology, Agios Savvas Anticancer Hospital, Athens, Greece., Germetaki T; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Gazouli I; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece., Dadouli K; Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, Larissa, Greece., Zarkavelis G; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece., Amylidi AL; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece., Tolia M; Department of Radiotherapy, School of Medicine, University of Crete, Heraklion, Greece., Mauri D; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
Publikováno v:
JNCI cancer spectrum [JNCI Cancer Spectr] 2021 Nov 16; Vol. 5 (6). Date of Electronic Publication: 2021 Nov 16 (Print Publication: 2021).
Autor:
Gazouli I; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece., Tsampalas S; Department of Urology, University Hospital of Ioannina, Ioannina, Greece., Tsimaris I; Department of Urology, Chatzikosta General Hospital, Ioannina, Greece., Zarkavelis G; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece., Grivas N; Department of Urology, Chatzikosta General Hospital, Ioannina, Greece.; European Board of Urology, PanHellenic Association for Continual Medical Research, Ioannina, Greece., Kampletsas E; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece., Papadaki A; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece., Mavroeidis L; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece., Ntellas P; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece., Gkoura S; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece., Tsali L; PACMeR Athens, PanHellenic Association for Continual Medical Research, Ioannina, Greece., Amylidi AL; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece., Vlachou MS; Medical School, University of Ioannina, Ioannina, Greece., Mauri D; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece.
Publikováno v:
Urology annals [Urol Ann] 2021 Jan-Mar; Vol. 13 (1), pp. 86-88. Date of Electronic Publication: 2021 Jan 19.